Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.190
-0.055 (-4.42%)
Nov 13, 2026, 4:00 PM EST - Market closed
Enlivex Market Cap
Enlivex has a market cap or net worth of $1.48 million as of November 13, 2026. It is the 48,592nd most valuable company in the world and the 6,485th biggest in the United States. Its market cap has decreased by 94.02% in one year.
Market Cap
1.48M
Enterprise Value
13.51M
1-Year Change
-94.02%
Global Rank
Country Rank
#6,485 United States
Category
ChartMarket Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $1.48M, a decrease of -98.54%. That is a compound annual growth rate of -42.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 1.48M | -99.11% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 2.03M |
| BioRestorative Therapies | 1.99M |
| HCW Biologics | 1.92M |
| Genprex | 1.88M |
| 60 Degrees Pharmaceuticals | 1.83M |
| Kairos Pharma | 1.73M |
| XORTX Therapeutics | 1.62M |
| Oragenics | 1.54M |